Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy's UK private price has shifted more than once in the past two years, and if you're trying to work out what you'd actually pay now, the honest answer is: it depends on your dose and your provider. Private Wegovy treatment is priced per pen, with costs varying by dose and what the clinic includes in that figure. Semaglutide (Wegovy) is a prescription-only medicine, so any legitimate supply requires a clinical assessment — the price you see should always reflect that. For a plain breakdown of where the UK private market currently sits, our full Wegovy cost guide walks through what drives those numbers.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Both, in practice. Wegovy's private pricing in the UK has always been dose-dependent (a 2.4mg maintenance pen costs more than a 0.5mg starter pen) so as patients move up the titration schedule, their monthly spend rises even if the per-pen price stays constant. That creates the impression of a rising price even when nothing has formally changed.
On top of that, supply constraints since 2023 pushed many providers to reprice upward, and manufacturing expansions through 2024–25 have eased availability without bringing prices back to earlier lows. As things stand in mid-2026, you can find a full breakdown of what UK private Wegovy treatment currently costs, typically reported at somewhere in the range of £149 to well over £200 per month at lower doses, with higher doses commanding higher figures, on our Wegovy price page, which also explains why figures vary by provider rather than following fixed tariffs. The Wegovy price chart we maintain gives context on how those figures have moved over time.
The MHRA's approval of the higher 7.2mg dose (first announced in January 2026 and extended to a dedicated single-dose pen in April 2026) has also added a new pricing tier. A maintenance dose at 7.2mg sits at the top of the cost range. Whether that tier is right for you is a clinical question, not a budgeting one. Worth knowing before you start comparing headline figures.
This is where a quick check takes less than a minute and can save you a genuine surprise. Before assuming one provider is cheaper than another, look at whether the quoted figure includes: a clinical consultation, the prescription fee, delivery, and any follow-up support if you have questions between doses. Many advertised prices are pen-only and assume you've already paid elsewhere for the prescription.
Aftercare is the item most commonly stripped from headline prices. A number of providers charge per message or per review if you want a dose-increase assessment or need advice after a side effect. Those fees add up quickly across a year of treatment. Our per-pen price guide explains what a complete cost should include so you can compare like for like.
There is also a safety dimension here. Sellers offering Wegovy at prices that look markedly lower than the market range (particularly via social media, without a clinical consultation) are a serious red flag. The MHRA has warned publicly about counterfeit weight-loss pens that have contained dangerous substances; reporting suspect sellers via the Yellow Card scheme is encouraged. The only safe route to a prescription medicine is through a pharmacy you can verify on the GPhC register.
We're not the cheapest option in the UK market. That's a deliberate choice. One transparent price covers the consultation, the prescription, the medicine, and next-working-day tracked delivery, nothing is stripped out and charged back later. Aftercare runs seven days a week. Every repeat order is reviewed by a real prescriber before dispatch, not processed automatically.
We don't offer discount codes, vouchers, or promotional pricing. A discounted prescription medicine from an unverified source is precisely where the counterfeit risk concentrates, so our position on codes is partly a compliance choice and partly a straightforward safety one. If you've found a code for Wegovy elsewhere, that alone is worth scrutinising.
Current treatment pricing is listed transparently on our treatment page, and our prescribers are happy to talk through which starting dose or titration path makes clinical sense before you commit. You can also read more about what Wegovy involves if you're still weighing up whether it's the right fit.
For most purchases, price is a reasonable proxy for value. For a prescription-only weight-management medicine, it answers the wrong question. The right questions are: is this genuine, licensed-supply medicine? Has a qualified prescriber assessed me? Is there clinical support if something goes wrong?
Wegovy is a Black Triangle medicine (it carries additional MHRA monitoring requirements) and the titration schedule exists specifically to reduce the risk of side effects. Skipping or rushing that process to save money, or sourcing pens from a seller operating without proper clinical oversight, creates risks that no price difference justifies. NHS guidance on semaglutide and NICE's appraisal of Wegovy (TA875) both underline that this medicine works best within a structured, supervised programme, not as an off-the-shelf purchase. The small print is the important bit here. Once you've confirmed you're buying from a verified, regulated source, then comparing the total package cost is entirely sensible. The 1mg dose cost page gives a worked example of how to break that down by stage of treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.